Ascendis Pharma A/S Reports Third Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Ascendis Pharma (ASND) Misses Q3 EPS by EUR0.04
November 30, 2016 4:11 PM ESTAscendis Pharma (NASDAQ: ASND) reported Q3 EPS of (EUR0.72), EUR0.04 worse than the analyst estimate of (EUR0.68).
For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.
... More
